NORMAX STORY

NORMAX STORY has been a member of Linktree for 3 years and joined in January 2023. Besides social media accounts, normax has populated their site with WEBSITE for Normax Biomed Limited (NRMX), Normax Extreme Social Impact (ESI) Blog, FACT: EXTREME COST of COVID-19, PATHOGENS & PANDEMIC RISK, WHO. 04 JAN 2023: "XBB.1.5 Most Transmissible Subvariant Yet.", BIOSECURITY: Inevitable Evolution of COVID and New Pathogens, EVERY 20 SECONDS in 2021... Somebody DIED of Tuberculosis (WHO), The MISSION of Normax (1:00), Normax IN-THE-NEWS, Normax PRESS ROOM, Normax on TWITTER, Normax on THE ROAD TO IRELAND with Pharma's Almanac (4:26), Normax SUMMARY, Normax FAQ, Normax at VALIDATE NETWORK, mRNA UCV Consortium by Normax, Normax SOCIAL VALUE (ESG) for Stakeholders and Investors, PURPOSE, CULTURE & VALUES of Normax, LOW-COST mRNA VACCINES for COVID, TB, HIV... by Normax, VACCINE EQUITY. mRNA Vaccines by Normax. Save a Life for $4.00, EDITORIAL. European Pharmaceutical Manufacturer. The time for mRNA vaccine equality across the globe by Peter Jensen, NO PANDEMICS by Normax. PATHOGENS and PANDEMICS. A Deadly Cost and Risk For All., GOAL 2050 by Normax. End transmission of TB and HIV by 2050., THE LANCET. 19.8 million deaths from COVID-19 averted during the first year of COVID-19 vaccination, REPORT. COVID-19 Vaccination program in U.S. saved 3.2 million lives and U.S. $1.15 trillion in 2 years, QUICK FACTS. mRNA Vaccine Technology & mRNA in Nature, OPEN ACCESS DATA. Scientific Reference & Review Digest, MARKET REPORTS. Long-Term Market Outlook for mRNA Vaccines and Therapeutics and SARS-CoV-2 Vaccines for Endemic COVID-19, MARKET DATA. Leading mRNA Biomedical & Biotech Companies, MARKET DATA. $110-$130 per Covid Vaccine by Moderna & Pfizer, MARKET DATA. Covid-19 mRNA Vaccines Lead Drug Sales 2021/22, BNTX Q3 2022 EXAMPLE: "€13.4 billion cash and cash equivalents plus total trade receivables of €7.3 billion", €300,000,000 CAPITAL COMMITMENT secured by Normax, Normax Story FOR INVESTORS in a few minutes..., Linkedin: Peter A. Jensen, CEO & Chairman, Normax Biomed Ltd..